RE:RE:What If.....SEGLTECH:
I agree, it would not be good for Biosyent (mainly) ..it would be good for GUD but then there would be two companies in one with different models.. perhaps in 4 or 5 years when RX gets much bigger and starts to target 100 mill aquisitions, then a merger might be good for both. Also unlike GUD which currently has "quite a bit of competition" RX has almost none right here..
Also, I hope RX is listening here niow, and I totally also agree that I would like to keep RX at 13 million shares if we can ... dillution is a killer ....do not let the investment bankers who would all love to do an underwriting for RX, talk you into it ... it is a big negative and few are smart enough to see it... If RX can continue to grow without dilluting the 6 other canadian pharma marketing companies I know of will be salivating and wishing they could be like rx... I Anyone here who has any insider's ears please echo this sentiment to them.. RX contiinue to be a leader, do not succomb and be a follower caving to the corrupt investment bankers who here would be VALUE KILLERS.....